Authors:
DEGREEF H
ANDREJEVIC L
AOKI F
AREND J
ASHTON R
DEBACKER W
BARTLETT K
VANBLOKLAND WB
BISHOP S
BOON R
BORBUJO J
CALZ AM
CANDAELE M
COLLINS P
CRAWFORD G
CVIJETIC O
DECROIX J
DECUYPER C
DELESCLUSE J
DEMAUBEUGE J
DUSCHET P
FRANSEN H
FRENK E
FRITSCH P
GHEERAERT P
GOETIJN M
GONZALEZ A
GOOSSEN J
GRCIC R
GRIFFIN D
GSCHNAIT F
HANSSENS Y
HARMS M
HOSANG M
ILIC V
ISENBERG Y
JANSEN A
JONES S
JOVOVIC D
KRAFFT T
KRANENDONK H
LALOSEVIC J
LEEN C
MARCIAS M
MCGOUGALL B
MCKENDRICK M
MILOJEVIC M
NABER F
NELEMANS F
NYE F
ONA MB
PARENT D
PORTNOY J
PRAK H
RANIN J
ROELFSEMA J
ROL H
ROOYAKKERS A
SACKS S
SHAFRAN S
SLEYFFERS BCMB
STALDER H
STEENHUISEN W
STEICHEN V
STEVANCEVIC Z
STRATENUS M
TAKIC C
TWYNHOLM M
VANDENCAMP M
VANDERENDT J
VANHECKE E
VERHELST A
VUJAKLIJA V
WADE A
WHITE J
WOOD M
ZERJAV S
Citation: H. Degreef et al., FAMCICLOVIR, A NEW ORAL ANTIHERPES DRUG - RESULTS OF THE FIRST CONTROLLED CLINICAL-STUDY DEMONSTRATING ITS EFFICACY AND SAFETY IN THE TREATMENT OF UNCOMPLICATED HERPES-ZOSTER IN IMMUNOCOMPETENT PATIENTS, International journal of antimicrobial agents, 4(4), 1994, pp. 241-246